1-3 of 3
Juan Navarro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bosutinib As Therapy for Chronic Phase Chronic Myeloid Leukemia Following Failure with Imatinib Plus Dasatinib and/or Nilotinib: 24-Month Minimum Follow-up Update

H. Jean Khoury, MD, Carlo Gambacorti-Passerini, Hagop M. Kantarjian, MD, Dong-Wook Kim, David Marin, Pedro E Dorlhiac-Llacer, Andrey Zaritskey, Juan Navarro, Eduardo O Bullorsky, Sarit Assouline, Eric Leip, Virginia Kelly, Kathleen Turnbull, Nadine Besson, Jorge E Cortes, MD
Journal: Blood
Blood (2012) 120 (21): 3785.
https://doi.org/10.1182/blood.V120.21.3785.3785
Published: 2012
Journal Articles

Bosutinib as Third-Line Treatment for Chronic Phase Chronic Myeloid Leukemia Following Failure of Second-Line Therapy with Dasatinib or Nilotinib

H. Jean Khoury, Dong-Wook Kim, MD, Andrey Zaritskey, Carlo Gambacorti-Passerini, Andreas Hochhaus, Juan Navarro, Aaron P. Rapoport, Pedro Enrique Dorlhiac-Llacer, Maria Zanichelli, Virginia Kelly, Nadine Besson, Trevor McMullan, Hagop M. Kantarjian, Jorge E. Cortes
Journal: Blood
Blood (2010) 116 (21): 892.
https://doi.org/10.1182/blood.V116.21.892.892
Published: 2010
Journal Articles

Clinical Outcomes in Adult T Leukemia/Lymphoma: Report of 55 Cases from Peru.

Brady E. Beltrán-Gárate, MD, Antonio A. Carrasco-Yalan, MD, Olga M. Lopéz-Odría, MD, Luis Riva-Gonzales, MD, Hugo Ríos, MD, Gloria Chumpitáz-Anchiraico, MD, Silvia Falcón-Lisarazo, MD, Juan Navarro-M, MD, Fernando Hurtado de Mendoza, MD, Jorge Castillo-Aguirre, MD
Journal: Blood
Blood (2005) 106 (11): 4797.
https://doi.org/10.1182/blood.V106.11.4797.4797
Published: 2005